BladdEr Full OR Empty for Pelvic Radiation Therapy

Description

The present study evaluates empty and full bladder protocols for radiation therapy of genitourinary (GU), gynecological (Gyn), and gastrointestinal (GI) malignancies of the pelvis.

Conditions

Pelvic Neoplasm

Talk to us

Study Overview

On this page

Study Details

Study overview

The present study evaluates empty and full bladder protocols for radiation therapy of genitourinary (GU), gynecological (Gyn), and gastrointestinal (GI) malignancies of the pelvis.

BladdEr Full OR Empty for Pelvic Radiation Therapy

BladdEr Full OR Empty for Pelvic Radiation Therapy

Condition
Pelvic Neoplasm
Intervention / Treatment

-

Contacts and Locations

San Diego

University of California, San Diego, San Diego, California, United States, 92093

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Provision of signed and dated informed consent form
  • * Stated willingness to comply with all study procedures and availability for the duration of the study
  • * Persons, aged at least 18 years
  • * Deemed eligible to undergo curative intent radiation therapy for primary GU, GI, or Gyn malignancy of the pelvis.
  • * For participants able to become pregnant: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation
  • * For participants able to cause a pregnancy: use of condoms or other methods to ensure effective contraception with partner
  • * Pregnancy
  • * Tumor invading the bladder, as judged by the enrolling physician based on available clinical information
  • * Contraindications to radiotherapy, including Crohn's disease and active connective tissue disorders such as scleroderma or uncontrolled lupus
  • * Prior radiation therapy to an area requiring treatment in the present study

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Diego,

Tyler Seibert, MD, PhD, PRINCIPAL_INVESTIGATOR, University of California, San Diego

Study Record Dates

2029-12